SCHEMBL5608003

SCHEMBL5608003

O=C(O)CC1(NI)CCCC1

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.45
ALDH1A1 P00352 3/20 0.42
CYP1A2 P05177 2/20 0.42
LMNA P02545 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
USP2 O75604 2/20 0.42
TSHR P16473 1/20 0.42
BLM P54132 1/20 0.42
CACNA2D1 P54289 1/20 0.42
HSD11B1 P28845 3/20 0.38
MAPK1 P28482 1/20 0.33
MME P08473 1/20 0.33
NPSR1 Q6W5P4 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
KMT2A Q03164 1/20 0.31
HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5608240 0.98 CYP2C19 (0.48) CYP2C19ALDH1A1CYP1A2LMNASMN1; SMN2
SCHEMBL23895993 0.95 CYP2C19 (0.40) CYP2C19ALDH1A1CYP1A2LMNASMN1; SMN2
SCHEMBL1825623 0.77 CYP2C19 (0.45) CYP2C19ALDH1A1CYP1A2LMNASMN1; SMN2
SCHEMBL5019821 0.76 CYP2C19 (0.48) CYP2C19ALDH1A1CYP1A2LMNASMN1; SMN2
SCHEMBL15798070 0.76 CYP2C19 (0.48) CYP2C19ALDH1A1CYP1A2LMNASMN1; SMN2
Hydrochloric Acid SCHEMBL27856474 0.74 CYP2C19 (0.47) CYP2C19ALDH1A1CYP1A2LMNASMN1; SMN2
SCHEMBL3373260 0.74 CYP2C19 (0.42) CYP2C19ALDH1A1CYP1A2LMNASMN1; SMN2
SCHEMBL3667120 0.72 CYP2C19 (0.45) CYP2C19ALDH1A1CYP1A2LMNASMN1; SMN2
SCHEMBL3369935 0.72 CYP2C19 (0.45) CYP2C19ALDH1A1CYP1A2LMNASMN1; SMN2
SCHEMBL27608123 0.72 CYP2C19 (0.45) CYP2C19ALDH1A1CYP1A2LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1863477-A1 3,4-SUBSTITUTED PYRROLIDINE DERIVATIVES FOR THE TREATMENT OF HYPERTENSION Novartis AG (CH) 2007-12-12 EP disclosed
WO-2006100036-A1 3, 4-SUBSTITUTED PYRROLIDINE DERIVATIVES FOR THE TREATMENT OF HYPERTENSION NOVARTIS AG (CH) 2006-09-28 WO disclosed